5 Biotechs Set Stage For $415M Wave Of IPOs
Five more biotechs — including cancer immunotherapy, painkiller, muscular dystrophy treatment and skin care developers, several of which are backed by venture capital firms — inched closer Monday to going public,...To view the full article, register now.
Already a subscriber? Click here to view full article